Driven by a passion for expanding patient access to innovative therapies, Dr. Ramesh Arjunji serves as executive vice president of value and access at Nanoscope Therapeutics. He has played a critical role in shaping strategies that connect scientific innovation with real-world impact. His cross-functional expertise spans commercial development, R&D, medical affairs, and business development in neurology, oncology, immunology, ophthalmology, metabolic diseases, and medical devices. 

Prior to joining Nanoscope, he served as Senior Vice President, Global Value and Access at Krystal Biotech, and earlier led evidence strategy as VP of Evidence Synthesis at SSI Strategy. Dr. Arunji has also held executive and senior leadership roles at several other organizations, including AveXis/Novartis, Alcon, Biogen, Pfizer, and Centocor/J&J.

Dr. Arjunji earned his PhD in Management Science at The University of Texas at Dallas, his Master of Science in Mechanical Engineering at Florida State University, and a Bachelor of Technology in Aeronautics/Aviation/Aerospace Science and Technology at the Indian Institute of Technology in Kanpur.